£3.1M
The funding round includes backing from The North West Fund for Biomedical, Innovate UK, and London Business Angels.
V
Videregen
Videregen develops biological scaffolds for organ replacement and regenerative medicine.
Liverpool, UK—Founded 2011
£4.4MTotal raised
Videregen is a Liverpool-based developer of regenerative medicine that creates bespoke organ replacements using biological scaffolds and patient stem cells.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from Videregen's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
SB
Steve Bloor
Chief Executive Officer
Steve brings regenerative medicine operating and research experience, having previously led Videregen and held senior roles at Covidien, TSL, and J&J.
LinkedInInvestors
- £3.1M
- £1.3M
Funding history
£1.3M
The Liverpool-based stem cell specialist raised the funds from founders, angels, and Spark Impact to scale manufacturing and run clinical trials.